PubMed:33125711 / 344-493 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T5","span":{"begin":71,"end":78},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T6","span":{"begin":71,"end":78},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"}],"text":"In addition, in the UK, Brazil and Australia, nebulised unfractionated heparin (UFH) is being trialled in COVID-19 patients as a potential treatment."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":71,"end":78},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"In addition, in the UK, Brazil and Australia, nebulised unfractionated heparin (UFH) is being trialled in COVID-19 patients as a potential treatment."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":106,"end":114},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"In addition, in the UK, Brazil and Australia, nebulised unfractionated heparin (UFH) is being trialled in COVID-19 patients as a potential treatment."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T2","span":{"begin":127,"end":128},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"In addition, in the UK, Brazil and Australia, nebulised unfractionated heparin (UFH) is being trialled in COVID-19 patients as a potential treatment."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":71,"end":78},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"In addition, in the UK, Brazil and Australia, nebulised unfractionated heparin (UFH) is being trialled in COVID-19 patients as a potential treatment."}

{"project":"LitCovid-PubTator","denotations":[{"id":"42","span":{"begin":71,"end":78},"obj":"Chemical"},{"id":"43","span":{"begin":80,"end":83},"obj":"Chemical"},{"id":"44","span":{"begin":106,"end":114},"obj":"Disease"},{"id":"45","span":{"begin":115,"end":123},"obj":"Species"}],"attributes":[{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:D006493"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:D006493"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:C000657245"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In addition, in the UK, Brazil and Australia, nebulised unfractionated heparin (UFH) is being trialled in COVID-19 patients as a potential treatment."}

{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":0,"end":149},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In addition, in the UK, Brazil and Australia, nebulised unfractionated heparin (UFH) is being trialled in COVID-19 patients as a potential treatment."}